artículo
A pilot multicenter randomized controlled trial comparing Bankart repair and remplissage with the Latarjet procedure in patients with subcritical bone loss (STABLE): study protocol
Fecha
2022Registro en:
10.1186/s40814-022-00987-4
2055-5784
Autor
Marinis Acle, Rodrigo Ignacio de
Khan, Moin
Bedi, Asheesh
Degen, Ryan
Warner, Jon
Bhandari, Mohit
Khan, Moin
Degen, Ryan
Bhandari, Mohit
Bedi, Asheesh
Warner, Jon
Madden, Kim
Barkhordari, Nazanin
Garrido Clua, Miriam
Wozny, Kelsey
Moro, Jaydeep
Denkers, Matthew
Ayeni, Olufemi R.
Litchfield, Robert
Bryant, Diane
Wanlin, Stacey
Firth, Andrew
Horst, Stephanie
Inch, Katelyn
Lapner, Peter
McIlquham, Katie
García Portabella, Montserrat
H. Núñez, Jorge
Batalla, Lledo
Massons, Josep
Henry, Patrick
Milner, Katrine
Ou, Yinmin
Kunz, Mónica
Álvares, Alicia
Moganathas, Saranjan
Chandrasegaram, Aarani
Oliogu, Etinosa
Balasuberamaniam, Phumeena
Gundi, Bárbara
Sivakumar, Nithila
Rashid, Khadija
Lewaniak, Stephanie
Fariha, Atqiya
Sri, Lavaneyaa
Alolabi, Bashar
Bolton, Carlee
Li, Xinning
Curry, Emily
Michlin, Dana
Bardana, Davide
Bicknell, Ryan
Liendo Verdugo, Rodrigo Javier
Vidal Olate, Catalina Victoria
Institución
Resumen
Introduction: Anterior dislocations, the most common type of shoulder dislocation, are often complicated by subsequent instability. With recurrent dislocations there often is attrition of the labrum and progressive loss of the anterior bony contour of the glenoid. Treatment options for this pathology involve either soft tissue repair or bony augmentation procedure. The optimal management remains unknown and current clinical practice is highly varied. Methods and analysis:The Shoulder instability Trial comparing Arthroscopic stabilization Benefits compared with Latarjet procedure Evaluation (STABLE) is an ongoing multi-centre, pilot randomized controlled trial of 82 patients who have been diagnosed with recurrent anterior shoulder instability and subcritical glenoid bone loss. Patients are randomized to either soft tissue repair (Bankart + Remplissage) or bony augmentation (Latarjet procedure). The primary outcome for this pilot is to assess trial feasibility and secondary outcomes include recurrent instability as well as functional outcomes up to two years post-operatively. Conclusions: This trial will help to identify the optimal treatment for patients with recurrent shoulder instability with a focus on determining which treatment option results in reduced risk of recurrent dislocation and improved patient outcomes. Findings from this trial will guide clinical practice and improve care for patients with shoulder instability. Ethics and dissemination: This study has ethics approval from the McMaster University/Hamilton Health Sciences Research Ethics Board (REB) (approval #4942). Successful completion will significantly impact the global management of patients with recurrent instability. This trial will develop a network of collaboration for future high-quality trials in shoulder instability.